Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1

Nature Medicine

Volumn 5, Issue 8, 1999, Pages 938-942

  Nakashima, Manabu ^a   Sonoda, Kenzo ^b   Watanabe, Takeshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; APOPTOSIS; ARTICLE; CELL GROWTH; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOSURVEILLANCE; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; APOPTOSIS; CELL DIVISION; CELL LINE; CLONING, MOLECULAR; DNA, COMPLEMENTARY; FLOW CYTOMETRY; GLUTATHIONE TRANSFERASE; HUMANS; MOLECULAR SEQUENCE DATA; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTE SUBSETS;

EID: 0032779988     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/11383     Document Type: Article

References (25)

1. van de Bruggen, P. et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254, 1643-1647 (1991).
2. Melief, C.J. & Kast, W.M. T-cell immunotherapy of cancer. Res. Immunol. 142, 425-429 (1991).
3. Barnd, D.L., Lan, M.S., Metzgar, R.S. & Finn, O.J. Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc. Natl. Acad. Sci. USA 86, 7159-7163 (1989).
4. Peiper, M. et al. The HER2/neu-derived peptide p654-662 is a tumor-associated antigen in human pancreatic cancer recognized by cytotoxic T lymphocytes. Eur. J. Immunol. 27, 1115-1123 (1997).
5. Van den Eynde, B.J. & Van der Bruggen, P. T cell defined tumor antigens. Curr. Opin. Immunol. 9, 684-693 (1997).
6. Sahin, U. Tureci, O. & Pfreundschuh, M. Serological identification of human tumor antigens. Curr. Opin. Immunol. 9, 709-716 (1997).
7. Becker, J.C. et al. Tumor escape mechanisms from immunosurveillance: induction of unresponsiveness in a specific MHC-restricted CD4+ human T cell clone by the autologous MHC class II+ melanoma. Int. Immunol. 5, 1501-1508 (1993).
8. Runger, T.M., Klein, C.E., Becker, J.C. & Brocker, E.B. The role of genetic instability, adhesion, cell motility, and immune escape mechanisms in melanoma progression. Curr. Opin. Oncol. 6, 188-196 (1994).
9. Edward, M. Integrins and other adhesion molecules involved in melanocytic tumor progression. Curr. Opin. Oncol. 7, 185-191 (1995).
10. Ferrone, S. & Marincola, F.M. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol. Today 16, 487-494 (1995).
11. Susanne, S. et al. Lymphocyte apoptosis induced by CD95(APO-1/Fas) ligand-expressing tumor cells - A mechanism of immune evasion? Nature Med. 2, 1361-1366 (1996).
12. Claude, D.G. et al. Breast cancer-associated antigen, DF3/MUC1, induces apoptosis of activated human T cells. Nature Med. 2, 1367-1370 (1996).
13. Hahne, M. et al. Melanoma cell expression of Fas(Apo-1/CD95) ligand: Implications for tumor immune escape. Science 274, 1363-1366 (1996).
14. Sonoda, K. et al. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Cancer 77, 1501-1509 (1996).
15. Sonoda, K. et al. Establishment of a new human uterine cervical adenocarcinoma cell line, SiSo, and its reactivity to anti-cancer reagents. Int. J. Oncol. 6, 1099-1104 (1995).
16. Sonoda, K. et al. Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias. Clinical Cancer Research 4, 1517-1520 (1998).
17. K. Hofmann and W. Stoffel. TMBASE - A database of membrane spanning protein segments. Biol. Chem. Hoppe-Seyler 374, 166 (1993).
18. Gossen, M. et al. Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766-1769 (1995).
19. Henkart, P.A. ICE family proteases: mediators of all apoptotic cell death? Immunity, 4, 195-201 (1996).
20. Munker, R. et al. Expression of CD95(FAS) by gene transfer does not sensitize K562 to Fas-killing. Hematol. Cell Ther. 39, 75-78 (1997).
21. Owen-Schaub L.B. et al. Wild-type human p53 and a temperture-sensitive mutant Induce Fas/APO-1 Expression. Mol. Cell. Biol. 15, 3032-3040 (1995).
22. Whiteside, T.L. & Herberman, R.B. The role of natural killer cells in immune surveillance of cancer. Curr. Opin. Immunol. 7, 704-710 (1995).
23. Kaku T. et al. The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix. Clinical Cancer Research (in the press).
24. Watanabe T. et al. Isolation of estrogen-responsive genes with a CpG island library. Mol. Cell. Biol. 18, 442-449 (1998).
25. Fukuda, T. et al. Restoration of surface IgM-mediated apoptosis in an anti-IgM-resistant variant of WEHI-231 lymphoma cells by HS-1, a protein-tyrosine kinase substrate. Proc. Natl. Acad. Sci. USA 92, 7302-7306 (1995).